Gilyadova Aida, Ishchenko Anton, Shiryaev Artem, Alekseeva Polina, Efendiev Kanamat, Karpova Radmila, Loshchenov Maxim, Loschenov Victor, Reshetov Igor
University Clinical Hospital No. 1, Levshin Institute of Cluster Oncology, Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation, 119435 Moscow, Russia.
National Medical Research Center Treatment and Rehabilitation Center, Ministry of Health of the Russian Federation, 125367 Moscow, Russia.
Cancers (Basel). 2022 Jan 2;14(1):211. doi: 10.3390/cancers14010211.
(1) Purpose: Improving the treatment effectiveness of intraepithelial neoplasia of the cervix associated with human papillomavirus infection, based on the application of the method of photodynamic therapy with simultaneous laser excitation of fluorescence to clarify the boundaries of cervical neoplasms. (2) Methods: Examination and treatment of 52 patients aged 22 to 53 years with morphologically and cytologically confirmed mild to severe intraepithelial cervix neoplasia, preinvasive, micro-invasive, and squamous cell cervix carcinoma. All patients were carriers of human papillomavirus infection. The patients underwent photodynamic therapy with simultaneous laser excitation of fluorescence. The combined use of video and spectral fluorescence diagnostics for cervical neoplasms made it possible to control the photodynamic therapy process at all stages of the procedure. Evaluation of the photodynamic therapy of intraepithelial cervical neoplasms was carried out with colposcopic examination, cytological conclusion, and morphological verification of the biopsy material after the photodynamic therapy course. The success of human papillomavirus therapy was assessed based on the results of the polymerase chain reaction. (3) Results. The possibility of simultaneous spectral fluorescence diagnostics and photodynamic therapy using a laser source with a wavelength of 660 nm has been established, making it possible to assess the fluorescence index in real-time and control the photobleaching of photosensitizers in the irradiated area. The treatment of all 52 patients was successful after the first photodynamic therapy procedure. According to the PCR test of the discharge from the cervical canal, the previously identified HPV types were not observed in 48 patients. Previously identified HPV types were absent after repeated PDT in four patients (CIN III ( = 2), CIS ( = 2)). In 80.8% of patients, regression of the lesion was noted. (4) Conclusions. The high efficiency of photodynamic therapy with intravenous photosensitizer administration of chlorin e6 has been demonstrated both in relation to eradication therapy of human papillomavirus and in relation to the treatment of intraepithelial lesions of the cervix.
(1)目的:基于应用光动力疗法并同时进行激光荧光激发以明确宫颈肿瘤边界的方法,提高与人乳头瘤病毒感染相关的宫颈上皮内瘤变的治疗效果。(2)方法:对52例年龄在22至53岁之间、经形态学和细胞学确诊为轻度至重度宫颈上皮内瘤变、原位癌、微浸润癌及鳞状细胞宫颈癌的患者进行检查和治疗。所有患者均为人乳头瘤病毒感染携带者。患者接受了同时进行激光荧光激发的光动力疗法。宫颈肿瘤的视频和光谱荧光诊断联合使用使得在该操作的各个阶段都能控制光动力治疗过程。在光动力治疗疗程结束后,通过阴道镜检查、细胞学结论以及活检材料的形态学验证对宫颈上皮内瘤变的光动力治疗进行评估。基于聚合酶链反应的结果评估人乳头瘤病毒治疗的成功率。(3)结果。已证实使用波长为660 nm的激光源进行同步光谱荧光诊断和光动力疗法是可行的,这使得能够实时评估荧光指数并控制照射区域内光敏剂的光漂白。在首次光动力治疗程序后,所有52例患者的治疗均成功。根据宫颈管分泌物的PCR检测,48例患者未检测到先前鉴定出的人乳头瘤病毒类型。4例患者(CIN III(=2),CIS(=2))在重复光动力治疗后未检测到先前鉴定出的人乳头瘤病毒类型。80.8%的患者病变出现消退。(4)结论。已证明静脉注射光敏剂氯e6的光动力疗法在人乳头瘤病毒根除治疗以及宫颈上皮内病变治疗方面均具有高效性。